Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAT | P00750 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.35 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23309560 | 0.85 | PLAT (0.37) | PLATRAB9AKDM4EALDH1A1HSD17B10 | |
| SCHEMBL23309579 | 0.82 | ALDH1A1 (0.49) | KDM4EALDH1A1HSD17B10TSHR | |
| SCHEMBL23309544 | 0.78 | TSHR (0.48) | KDM4EALDH1A1HPGDHSD17B10TSHR | |
| SCHEMBL23309561 | 0.77 | USP2 (0.40) | RAB9AKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL23309552 | 0.77 | TSHR (0.54) | RAB9AKDM4EALDH1A1HSD17B10TSHR | |
| SCHEMBL23309629 | 0.77 | CYP3A4 (0.34) | ALDH1A1HSD17B10TSHR | |
| SCHEMBL23309549 | 0.77 | CYP3A4 (0.34) | ALDH1A1HSD17B10TSHR | |
| SCHEMBL23309648 | 0.76 | NPC1 (0.51) | HSD17B10TSHR | |
| SCHEMBL23309661 | 0.75 | CYP3A4 (0.50) | KDM4EALDH1A1HPGDHSD17B10TSHR | |
| SCHEMBL23309619 | 0.73 | NPC1 (0.40) | RAB9AKDM4EALDH1A1GLAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2021-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | BROX, ALG1, CTRL | PLAT 4449/4885RAB9A 286/4885SLC13A3 4610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.